Billiontoone (NASDAQ:BLLN – Get Free Report) and CVS Health (NYSE:CVS – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership and valuation.
Valuation & Earnings
This table compares Billiontoone and CVS Health”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Billiontoone | $305.11 million | 16.70 | $7.45 million | $0.92 | 117.34 |
| CVS Health | $420.61 billion | 0.27 | $1.77 billion | $8.59 | 10.40 |
CVS Health has higher revenue and earnings than Billiontoone. CVS Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and price targets for Billiontoone and CVS Health, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Billiontoone | 1 | 3 | 7 | 0 | 2.55 |
| CVS Health | 0 | 2 | 23 | 0 | 2.92 |
Billiontoone presently has a consensus target price of $124.38, suggesting a potential upside of 15.21%. CVS Health has a consensus target price of $107.79, suggesting a potential upside of 20.65%. Given CVS Health’s stronger consensus rating and higher probable upside, analysts plainly believe CVS Health is more favorable than Billiontoone.
Insider & Institutional Ownership
80.7% of CVS Health shares are owned by institutional investors. 50.2% of Billiontoone shares are owned by company insiders. Comparatively, 0.9% of CVS Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Billiontoone and CVS Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Billiontoone | 10.95% | 9.16% | 6.78% |
| CVS Health | 2.62% | 13.65% | 4.20% |
Summary
CVS Health beats Billiontoone on 8 of the 13 factors compared between the two stocks.
About Billiontoone
BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company’s molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient’s blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.
About CVS Health
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
